Video
3 Jul 2026
Pharmaceutical Research and Development Center
At Indovinya, innovation drives everything we do. Through our state-of-the-art R&D Center, we support our partners and customers in finding the right excipient for their formulations across the pharmaceutical industry.
Together, we are shaping the future by advancing well-being and health.
Watch the video to see how we deliver value in the pharmaceutical segment (human and animal)!
Content provided by our supplier
Indorama Ventures: Indovinya
-
Country/Region:Brazil
-
On CPHI since:2026
-
Employees:1000 - 4999
Company types
Other Content from Indorama Ventures: Indovinya (3)
-
News Indovinya Expands Nutrition & Health Portfolio with Launch of Dual-Grade Glycerin for Food and Pharma Applications in the U.S.
New dual-grade glycerin enables manufacturers to streamline supply chains while meeting stringent regulatory and quality requirements. -
News Indovinya Strengthens European Pharma Excipient Footprint with Launch of OXIPURITY® PEG Powder Portfolio
New polyethylene glycol (PEG) powder portfolio, supported by European partnerships and dedicated technical support, enhances process efficiency for highly regulated pharmaceutical applications. -
Video Applied Formulation Science: the strategic role of excipients
In pharmaceutical development, performance goes far beyond the active pharmaceutical ingredient (API). Stability, bioavailability, scalability, and patient experience are all shaped by formulation decisions — and excipients play a strategic role in making innovation reliable.
In this episode of the Indovinya Expert Series, Hemyle Chaves, Pharma Researcher at Indovinya, shares how applied formulation science, excipient chemistry, and data‑driven insights support robust, compliant, and scalable pharmaceutical formulations.
From topical applications to predictive models and formulation flexibility, discover how the right excipient selection helps reduce risk, increase robustness, and ensure consistent performance from lab to industry.